In the wake of the increase in Current Liabilities in the second quarter 2024, Quick Ratio fell to 0 a new company low.

Within Major Pharmaceutical Preparations industry 551 other companies have achieved higher Quick Ratio than Axim Biotechnologies Inc in second quarter 2024. While Quick Ratio total ranking in the second quarter 2024 has deteriorated compared to the prior quarter from 2977 to 5493.

Explain Quick Ratio?
How much Cash & cash equivalents AXIM�s has?
What are AXIM�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AXIM Quick Ratio	(Jun 30 2024) Q2	(Mar 31 2024) Q1	(Dec 31 2023) Q4	(Sep 30 2023) Q3	(Jun 30 2023) Q2
Y / Y Current Liabilities Change	-26.9 %	-8.42 %	69.27 %	35.25 %	208.52 %
Y / Y Cash & cash equivalent Change	-91.54 %	-84.6 %	-82.76 %	-80.9 %	51.81 %
Quick Ratio MRQ	0	0	0	0.01	0.01
AXIM's Total Ranking	# 5493	# 2977	# 3552	# 3813	# 4205
Seq. Current Liabilities Change	37.31 %	-21.34 %	32.34 %	-48.86 %	72.01 %
Seq. Cash & cash equivalent Change	0 %	0 %	-72.04 %	-69.74 %	81.94 %

Quick Ratio second quarter 2024 Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 552
Healthcare Sector	# 1133
Overall Market	# 5493

Quick Ratio Statistics
High	Average	Low
3.28	0.28	0
(Sep 30 2011)		(Dec 31 2013)

Financial Statements
Axim Biotechnologies Inc 's Current Liabilities	$ 6 Millions	Visit AXIM's Balance sheet
Axim Biotechnologies Inc 's Cash & cash equivalent	$ 0 Millions	Visit AXIM's Balance sheet
Source of AXIM's Sales		Visit AXIM's Sales by Geography

Cumulative Axim Biotechnologies Inc 's Quick Ratio

AXIM's Quick Ratio for the trailling 12 Months

AXIM Quick Ratio	(Jun 30 2024) 12 Months	(Mar 31 2024) 12 Months	(Dec 31 2023) 12 Months	(Sep 30 2023) 12 Months	(Jun 30 2023) 12 Months
Y / Y Current Liabilities TTM Growth	3.91 %	61.61 %	84.16 %	76.46 %	92.58 %
Y / Y Cash & cash equivalent TTM Growth	-84.65 %	-55.17 %	-70.71 %	-77.51 %	-69.83 %
Quick Ratio TTM	0	0.01	0.01	0.01	0.02
Total Ranking TTM	# 4031	# 2425	# 3177	# 3403	# 3674
Seq. Current Liabilities TTM Growth	-9.89 %	-1.77 %	11.11 %	5.65 %	40.15 %
Seq. Cash & cash equivalent TTM Growth	-62.19 %	-24.01 %	-17.34 %	-35.36 %	10.39 %

Quick ratio ranking by company, industry and sector >> Back to AXIM Financial Strength Comparisons >> Go to Compare AXIM Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in AXIM's Current Liabilities to $6.12 millions, cumulative Quick Ratio to 0 below the AXIM average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 502 other companies have achieved higher Quick Ratio than Axim Biotechnologies Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2024 from 2425 to 4031.

Explain Quick Ratio?
How much Cash & cash equivalents AXIM�s has?
What are AXIM�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Major Pharmaceutical Preparations Industry	# 503
Healthcare Sector	# 1045
Within the Market	# 4031

trailing twelve months Quick Ratio Statistics
High	Average	Low
0.63	0.22	0
(Sep 30 2014)		(Jun 30 2024)

Companies with similar Quick Ratio in the quarter ending Jun 30 2024, within Major Pharmaceutical Preparations Industry	Quick Ratio	Jun 30 2024 MRQ Cash & cash equivalent	Jun 30 2024 MRQ Current Liabilities
Provectus Biopharmaceuticals Inc	0.00	$ 0.030 Millions	$ 8.369 Millions
Panbela Therapeutics Inc	0.00	$ 0.059 Millions	$ 16.788 Millions
Os Therapies Incorporated	0.00	$ 0.095 Millions	$ 28.306 Millions
Orgenesis Inc	0.00	$ 0.077 Millions	$ 31.700 Millions
Semnur Pharmaceuticals Inc	0.00	$ 0.014 Millions	$ 6.594 Millions
Skinvisible Inc	0.00	$ 0.007 Millions	$ 4.024 Millions
Axim Biotechnologies Inc	0.00	$ 0.009 Millions	$ 6.115 Millions
Avenir Wellness Solutions Inc	0.00	$ 0.019 Millions	$ 12.970 Millions
Bioadaptives Inc	0.00	$ 0.003 Millions	$ 1.930 Millions
Biostax Corp	0.00	$ 0.005 Millions	$ 5.308 Millions

Date modified: 2026-09-08T15:11:18+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.